Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia

Status:
Completed

Trial end date:
2013-11-01

Target enrollment:

Participant gender:

This study will compare Z160 and placebo in patients with Postherpetic Neuralgia for safety and efficacy for a period of 6 weeks.

Phase 2

Zalicus